On March 27, 2024, Ann & Robert H. Lurie Children’s Hospital of Chicago treated its first patient with ELEVIDYS (delandistrogene moxeparvovec-rokl), the first gene therapy
Medical device cybersecurity was an afterthought for the industry and regulators for years, even as hackers continually targeted the healthcare sector. That changed last year
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: QuidelOrtho said it has withdrawn
VANCOUVER, BC, March 19, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development company, announced that
Toronto, Ontario–(Newsfile Corp. – April 3, 2024) – Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”) a clinical-stage biotechnology
Share this article Jynneos was a driver of Bavarian Nordic’s 2023 revenue surge. Credits: Richard H Grant/Shutterstock.com Following Bavarian Nordic’s announcement of the US commercial
LONDON — Moderna may be best known for its Covid-19 vaccine, but since its start, it’s always been set on developing therapies. It’s run into
MORRISTOWN, N.J., April 03, 2024 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc., a venture backed clinical-stage biopharmaceutical company committed to pushing the boundaries of neuroscience, today
VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the
The Food and Drug Administration approved a new device from Abbott meant to treat tricuspid heart valve disease — an expected decision after an outside